Tomorrow (December 6), DEA Co., Ltd., a well-known diamond ring brand in China, will apply for new shares. The issue price of DEA shares is as high as 116.88 yuan / share, which is the tenth highest priced new shares this year, and its issue price earnings ratio has also reached 86.51 times.
The average single sign profit of the five registered new shares listed this week exceeded 20000 yuan. Among them, one hundred yuan new shares of core guide technology can earn 26900 yuan; If calculated according to the highest intraday price on the first day of listing, the winning one can earn up to 42100 yuan.
the 12th 100 yuan new share this year
Five registered new shares were listed this week, with an average increase of 94.34% on the first day of listing, and the average single sign profit was 21500 yuan.
The single sign profits of the three new shares on the science and Innovation Board exceeded 20000 yuan. Dingyang science and technology can earn 29900 yuan, Xindao science and technology can earn 26900 yuan, and Juxin science and technology can earn 20000 yuan. For the two gem new shares, the single signature profit is less than 20000 yuan.
It is worth mentioning that the new shares of core technology on the science and innovation board listed on December 1 have an issue price of 134.81 yuan / share and an issue price earnings ratio of 112.96 times. Core guide technology closed up 39.92% on the first day of listing, with a single signing profit of 26900 yuan. If calculated according to the highest intraday price of 219 yuan, the first signing can earn up to 42100 yuan.
Following this week’s Baiji Shenzhou, another 100 yuan new shares will be launched next week. The issuance price of DEA shares, a new gem share subscribed next Monday, is as high as 116.88 yuan / share, with an issuance P / E ratio of 86.51 times, a reference Industry P / E ratio of 23.87 times and an over raised multiple of 3.46 times.
According to the data, DEA Co., Ltd. is a well-known diamond ring brand in China. It is mainly engaged in brand operation, customized sales, R & D and design of jewelry, and customized diamond inlaid jewelry such as proposal diamond rings for people in love and marriage. At present, Kwai DR has more than 20 million fans in micro-blog, WeChat, jitter, and tiktok.
Data show that since this year, there have been 12 new shares with an issue price of more than 100 yuan, and DEA shares ranked 10th. Four of the 12 100 yuan new shares had a single signature profit of more than 100000 yuan, while Liaoning Chengda Biotechnology Co.Ltd(688739) listed at the end of October broke on the first day of listing.
list of new share subscription information next week
According to the IPO arrangement, 11 new shares will be subscribed in Shanghai and Shenzhen next week, including 2 on the science and innovation board, 6 on the gem, 2 on the Shanghai main board and 1 on the Shenzhen main board.
Huayan precision machine: mainly engaged in the design, R & D, production and sales of bottle blank intelligent forming system and bottle blank mould
DEA shares: is mainly engaged in brand operation, customized sales, R & D and design of jewelry
products and environmental energy: mainly engaged in comprehensive utilization services of environmental protection and energy
bright moon lens: mainly engaged in the R & D, design, production and sales of ophthalmic products such as lenses, lens raw materials, finished lenses and frames
temus: mainly engaged in the R & D, production and sales of knitted fabrics and knitted clothing
Fengguang Co., Ltd.: is mainly engaged in the R & D, production and sales of chemical additives for polymer materials
Yong’an Futures: mainly engaged in commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management and fund sales
Baicheng medicine: mainly engaged in pharmaceutical research and development and technology industrialization
Hemai Co., Ltd.: is mainly engaged in the R & D, manufacturing and sales of photovoltaic inverter and other power conversion equipment, complete electrical equipment and related products
Hendi pharmaceutical: mainly engaged in the R & D, production and sales of chemical API and preparation products
South Grid Technology: apply clean energy technology and new generation information technology to ensure the safe operation and efficiency improvement of power energy system and promote the clean and intelligent development of power energy system by providing a comprehensive solution of “technical service + intelligent equipment”
(China Securities Journal)
